Dr Fiona Blackhall, a senior lecturer
in The University of Manchester's Institute of Cancer Sciences and a consultant based at The Christie NHS Foundation Trust — both part of the Manchester Cancer Research Centre — said: «In order to introduce precision medicine, where each cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.&raqu
in The University of Manchester's Institute of Cancer Sciences and a consultant based at The Christie NHS Foundation Trust — both part of the Manchester Cancer
Research Centre — said: «
In order to introduce precision medicine, where each cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.&raqu
In order to introduce precision medicine, where each cancer patient receives treatment designed to target the
genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to
standard chemotherapy treatment.»
The
research team, led by Nobel laureate Hamilton Smith, ordered short strands of
genetic code from commercial DNA synthesis companies
in the U.S. and Germany and stitched them into longer and longer strands using
standard molecular biology techniques.
Catalyse a new generation of
research on the
genetic basis of drug resistance and of other forms of biological adaptation
in pathogen populations, by providing a
standard analytical framework for the design and interpretation of genome - wide association studies.